These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 9432684
1. [Surgical therapeutic strategy in non-small-cell bronchial carcinoma]. Branscheid D. Praxis (Bern 1994); 1997 Oct 15; 86(42):1635-9. PubMed ID: 9432684 [Abstract] [Full Text] [Related]
2. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis]. Huang GJ, Fang DK, Cheng GY, Zhang DC. Zhonghua Zhong Liu Za Zhi; 2006 Jan 15; 28(1):62-4. PubMed ID: 16737625 [Abstract] [Full Text] [Related]
3. [Multimodal treatment of non small cell lung cancer]. Stoelben E, Digel W, Henke M, Passlick B. Zentralbl Chir; 2006 Apr 15; 131(2):110-4. PubMed ID: 16612776 [Abstract] [Full Text] [Related]
5. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y. Ann Thorac Surg; 2006 Jan 15; 81(1):292-7. PubMed ID: 16368383 [Abstract] [Full Text] [Related]
6. Tumor size and extension of lymph node metastases in N2 lung cancer. Watanabe Y, Murakami S, Oda M, Ohta Y, Watanabe S, Nozawa H, Kamesui T, Nozaki Y, Nonomura A, Minato H, Kitagawa M. Ann Ital Chir; 1999 Jan 15; 70(6):889-92. PubMed ID: 10804667 [Abstract] [Full Text] [Related]
7. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer]. Pan TC, Zheng Z, Li J, Chen T, Liu LG, Wei X. Ai Zheng; 2007 Mar 15; 26(3):303-6. PubMed ID: 17355796 [Abstract] [Full Text] [Related]
8. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB. Ann Thorac Surg; 2005 Jul 15; 80(1):268-74; discussion 274-5. PubMed ID: 15975380 [Abstract] [Full Text] [Related]
9. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer. Yildizeli B, Fadel E, Mussot S, Fabre D, Chataigner O, Dartevelle PG. Eur J Cardiothorac Surg; 2007 Jan 15; 31(1):95-102. PubMed ID: 17126556 [Abstract] [Full Text] [Related]
10. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. Yildizeli B, Dartevelle PG, Fadel E, Mussot S, Chapelier A. Ann Thorac Surg; 2008 Oct 15; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134 [Abstract] [Full Text] [Related]
11. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease. Hsu CP, Hsia JY, Chang GC, Chuang CY, Shai SE, Yang SS, Lee MC, Kwan PC. J Thorac Cardiovasc Surg; 2009 Aug 15; 138(2):426-33. PubMed ID: 19619791 [Abstract] [Full Text] [Related]
13. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer. Muraoka M, Akamine S, Oka T, Tagawa T, Nakamura A, Tsuchiya T, Hayashi T, Nagayasu T. Eur J Cardiothorac Surg; 2007 Aug 15; 32(2):356-61. PubMed ID: 17513118 [Abstract] [Full Text] [Related]
14. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma. Bodendorf MO, Haas V, Laberke HG, Blumenstock G, Wex P, Graeter T. Lung Cancer; 2009 Apr 15; 64(1):71-8. PubMed ID: 18790545 [Abstract] [Full Text] [Related]
15. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP. Eur J Surg Oncol; 2006 Jun 15; 32(5):583-7. PubMed ID: 16621424 [Abstract] [Full Text] [Related]
16. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime]. Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Zentralbl Chir; 2004 Aug 15; 129(4):270-5. PubMed ID: 15354247 [Abstract] [Full Text] [Related]
17. [Relatively non-curative resection for lung cancer: is this a complete resection?]. Nonaka M, Kadokura M, Yamamoto S, Kataoka D, Iyano K, Kawada T, Takaba T. Kyobu Geka; 2000 Aug 15; 53(9):759-62. PubMed ID: 10935403 [Abstract] [Full Text] [Related]
18. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. Deslauriers J, Grégoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y. Ann Thorac Surg; 2004 Apr 15; 77(4):1152-6; discussion 1156. PubMed ID: 15063224 [Abstract] [Full Text] [Related]
19. Surgical treatment of primary lung cancer with synchronous brain metastases. Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC. J Thorac Cardiovasc Surg; 2001 Sep 15; 122(3):548-53. PubMed ID: 11547308 [Abstract] [Full Text] [Related]
20. [Long-term results following resection for T3 non-small cell lung cancer]. Maniwa Y, Okada M, Yamamoto H. Kyobu Geka; 1998 Oct 15; 51(11):939-43. PubMed ID: 9789424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]